HCAT HEALTH CATALYST INC

Ownership history in Palogic Value Management, L.P.  ·  5 quarters on record

This page tracks every 13F SEC filing in which Palogic Value Management, L.P. reported a position in HEALTH CATALYST INC (HCAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.98% (2025 Q1)
Avg. % of fund
1.3%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,270,041 +178,222 +16.3% 1.27% $3.0M $2.39
2025 Q3 ADDED 1,091,819 +361,719 +49.5% 1.25% $3.1M $2.85
2025 Q2 ADDED 730,100 +53,200 +7.9% 1.12% $2.8M $3.77
2025 Q1 ADDED 676,900 +356,900 +111.5% 1.98% $4.6M $4.53
2024 Q4 INITIATED 320,000 0.88% $2.3M $7.07
% of Fund (quarterly)    HCAT price (monthly, adj. close)
← Back to Palogic Value Management, L.P. Holdings